Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ejenta is a private digital health company that provides an AI-powered connected care platform for remote patient monitoring and virtual care. The company’s technology was developed from NASA-originated intelligent agent software and is used to learn from connected devices, sensor data, and medical records to detect abnormalities, predict health deterioration, and support care-team workflows. Ejenta appears focused on commercial deployment rather than drug development, with offerings aimed at healthcare providers, payers, and space-health applications. Public materials highlight work in heart failure monitoring, chronic disease management, and spaceflight healthcare support, as well as collaborations with organizations such as Point32Health, AWS, NASA, and TRISH. The company is best characterized as a commercial health AI and remote care platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ejenta.